GlassScriptPhysician profile
Michael A Cosgrove
NPI 1750459616
$25,162.55
in general payments reported to CMS, 2019-2025
28 companies · $1,746 in 2025
The $1,746 reported for 2025 was more than what 79% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,148 · 2020: $4,138 · 2021: $5,468 · 2022: $4,817 · 2023: $5,724 · 2024: $2,122 · 2025: $1,746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,611 · Consulting Fee: $1,500 · Travel and Lodging: $1,481.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,611.06 |
| Consulting Fee | $1,500.00 |
| Travel and Lodging | $1,480.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $20,109.33 | 2019-2025 | Proclaim, Eterna, Octrode |
| Saluda Medical Americas, INC. | $2,686.47 | 2023-2025 | Evoke Scs, Evoke |
| Horizon Therapeutics Plc | $431.53 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $375.09 | 2019-2022 | |
| Zyla Life Sciences, INC. | $194.96 | 2019-2020 | |
| Redhill Biopharma INC. | $171.02 | 2020-2022 | |
| Almatica Pharma LLC | $167.58 | 2021-2022 | |
| Mml US, INC. | $136.03 | 2024 | Reactiv8 |
| Averitas Pharma INC. | $109.99 | 2023 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.83 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $78.45 | 2021-2024 | Xtampza |
| Arbor Pharmaceuticals, INC. | $77.26 | 2019-2021 | |
| Boston Scientific Corporation | $64.39 | 2019-2025 | Intracept, Spectra Wavewriter |
| Ibsa Pharma INC. | $63.08 | 2022 | |
| Medtronic, INC. | $61.54 | 2022-2023 | Kyphon Express II Kyphopak Tray |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $52.41 | 2023-2025 | Botox |
| Radius Health, INC. | $40.25 | 2022 | |
| Assertio Therapeutics, INC. | $38.27 | 2020 | |
| Curonix LLC | $31.59 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Pfizer INC. | $25.01 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $22.34 | 2024 | Iovera, Zilretta, Exparel |
| Avanos Medical | $22.10 | 2020 | |
| Stimwave Technologies Incorporated | $21.75 | 2019 | |
| Iroko Pharmaceuticals, LLC | $18.83 | 2019 | |
| Pacira Therapeutics, INC. | $16.93 | 2020 | |
| Depuy Synthes Sales INC. | $16.32 | 2023 | Orthovisc |
| Medtronic USA, INC. | $13.03 | 2020 | |
| Biodelivery Sciences International, INC. | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cosgrove listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.